BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29665645)

  • 1. MicroRNA-195 regulates docetaxel resistance by targeting clusterin in prostate cancer.
    Ma X; Zou L; Li X; Chen Z; Lin Q; Wu X
    Biomed Pharmacother; 2018 Mar; 99():445-450. PubMed ID: 29665645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.
    Wang Y; Lieberman R; Pan J; Zhang Q; Du M; Zhang P; Nevalainen M; Kohli M; Shenoy NK; Meng H; You M; Wang L
    Mol Cancer; 2016 Nov; 15(1):70. PubMed ID: 27832783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-323 upregulation promotes prostate cancer growth and docetaxel resistance by repressing p73.
    Gao Q; Zheng J
    Biomed Pharmacother; 2018 Jan; 97():528-534. PubMed ID: 29091904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-223-3p regulates cell chemo-sensitivity by targeting FOXO3 in prostatic cancer.
    Feng Q; He P; Wang Y
    Gene; 2018 Jun; 658():152-158. PubMed ID: 29518547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells.
    Qiu X; Wang W; Li B; Cheng B; Lin K; Bai J; Li H; Yang G
    BMC Cancer; 2019 Jan; 19(1):27. PubMed ID: 30621625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.
    Zhong B; Sallman DA; Gilvary DL; Pernazza D; Sahakian E; Fritz D; Cheng JQ; Trougakos I; Wei S; Djeu JY
    Mol Cancer Ther; 2010 Jun; 9(6):1831-41. PubMed ID: 20501799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-181a promotes docetaxel resistance in prostate cancer cells.
    Armstrong CM; Liu C; Lou W; Lombard AP; Evans CP; Gao AC
    Prostate; 2017 Jun; 77(9):1020-1028. PubMed ID: 28485104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells.
    Patterson SG; Wei S; Chen X; Sallman DA; Gilvary DL; Zhong B; Pow-Sang J; Yeatman T; Djeu JY
    Oncogene; 2006 Oct; 25(45):6113-22. PubMed ID: 16652143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clusterin mediates TRAIL resistance in prostate tumor cells.
    Sallman DA; Chen X; Zhong B; Gilvary DL; Zhou J; Wei S; Djeu JY
    Mol Cancer Ther; 2007 Nov; 6(11):2938-47. PubMed ID: 18025278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
    Corcoran C; Rani S; O'Driscoll L
    Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1.
    Zhang G; Tian X; Li Y; Wang Z; Li X; Zhu C
    Biomed Pharmacother; 2018 Jan; 97():736-744. PubMed ID: 29102917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer.
    Gu X; Xue JQ; Han SJ; Qian SY; Zhang WH
    Cancer Biomark; 2016; 16(3):395-403. PubMed ID: 27062696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel.
    Yang Z; Chen JS; Wen JK; Gao HT; Zheng B; Qu CB; Liu KL; Zhang ML; Gu JF; Li JD; Zhang YP; Li W; Wang XL; Zhang Y
    J Exp Clin Cancer Res; 2017 Dec; 36(1):178. PubMed ID: 29216925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205.
    Puhr M; Hoefer J; Schäfer G; Erb HH; Oh SJ; Klocker H; Heidegger I; Neuwirt H; Culig Z
    Am J Pathol; 2012 Dec; 181(6):2188-201. PubMed ID: 23041061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The UCA1/miR-204/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells.
    Wang X; Yang B; Ma B
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):1025-1031. PubMed ID: 27686228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis.
    Li B; Jin X; Meng H; Hu B; Zhang T; Yu J; Chen S; Guo X; Wang W; Jiang W; Wang J
    Oncotarget; 2017 Jul; 8(29):47849-47860. PubMed ID: 28599307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells.
    Shi GH; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Zhu Y; Zhu YP; Xiao WJ; Ma CG
    Acta Pharmacol Sin; 2010 Jul; 31(7):867-73. PubMed ID: 20581857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancer.
    Shiota M; Zoubeidi A; Kumano M; Beraldi E; Naito S; Nelson CC; Sorensen PH; Gleave ME
    Mol Cancer Res; 2011 Dec; 9(12):1755-66. PubMed ID: 21987172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyceryl trinitrate‑induced cytotoxicity of docetaxel‑resistant prostatic cancer cells is associated with differential regulation of clusterin.
    Bouaouiche S; Magadoux L; Dondaine L; Reveneau S; Isambert N; Bettaieb A; Jeannin JF; Laurens V; Plenchette S
    Int J Oncol; 2019 Apr; 54(4):1446-1456. PubMed ID: 30720069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.